Abstract
Although advances in graft procurement, preservation, matching and immunosuppression have all contributed to todays outstanding short-term graft survival rates after solid organ transplantation, similar success has not been achieved in preventing chronic transplant dysfunction (CTD) and extending long-term graft survival. CTD is being recognized as one of the major causes of long-term ( > 5 years) graft loss. CTD is featured by obliteration of the vascular lumen as a result of occlusive neointima formation referred to as transplant arteriopathy (TA). Uncontrolled proliferation (hyperplasia) of smooth muscle cells (SMCs) is in major part responsible for neointima formation in TA. Endothelial cells (ECs) cover the neointima and form the barrier between the circulating blood and the vascular wall. The etiology of TA is largely unknown and development of TA is refractory to most anti-rejection therapies. Recent data attribute an important role to host-derived vascular progenitor cells in the development of TA, and these cells may be recruited from various sources including the bone marrow. Vascular progenitor cells are potential targets for therapeutic intervention to attenuate TA development. Therefore, understanding the molecular pathways that promote recruitment of vascular progenitor cells, that determine their differentiation fate, and that determine the proliferative capacity of their progeny, is warranted to dissect their detrimental and possible beneficial effects in the development of TA.
Keywords: Arteriopathy, endothelium, progenitor cell, rejection, smooth muscle, stem cell, transplantation
Current Genomics
Title: Vascular Progenitor Cells in the Development of Transplant Arteriopathy
Volume: 6 Issue: 6
Author(s): J. L. Hillebrands, H. Rienstra, G. Onuta and J. Rozing
Affiliation:
Keywords: Arteriopathy, endothelium, progenitor cell, rejection, smooth muscle, stem cell, transplantation
Abstract: Although advances in graft procurement, preservation, matching and immunosuppression have all contributed to todays outstanding short-term graft survival rates after solid organ transplantation, similar success has not been achieved in preventing chronic transplant dysfunction (CTD) and extending long-term graft survival. CTD is being recognized as one of the major causes of long-term ( > 5 years) graft loss. CTD is featured by obliteration of the vascular lumen as a result of occlusive neointima formation referred to as transplant arteriopathy (TA). Uncontrolled proliferation (hyperplasia) of smooth muscle cells (SMCs) is in major part responsible for neointima formation in TA. Endothelial cells (ECs) cover the neointima and form the barrier between the circulating blood and the vascular wall. The etiology of TA is largely unknown and development of TA is refractory to most anti-rejection therapies. Recent data attribute an important role to host-derived vascular progenitor cells in the development of TA, and these cells may be recruited from various sources including the bone marrow. Vascular progenitor cells are potential targets for therapeutic intervention to attenuate TA development. Therefore, understanding the molecular pathways that promote recruitment of vascular progenitor cells, that determine their differentiation fate, and that determine the proliferative capacity of their progeny, is warranted to dissect their detrimental and possible beneficial effects in the development of TA.
Export Options
About this article
Cite this article as:
Hillebrands L. J., Rienstra H., Onuta G. and Rozing J., Vascular Progenitor Cells in the Development of Transplant Arteriopathy, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483007
DOI https://dx.doi.org/10.2174/138920205774483007 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Current Pharmaceutical Design Identification of a Therapeutic Dose of Continuously Delivered Erythropoietin in the Eye Using An Inducible Promoter System
Current Gene Therapy Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Current Vascular Pharmacology Astragalin Attenuates UVB Radiation-induced Actinic Keratosis Formation
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Baccharis trimera Improves the Antioxidant Defense System and Inhibits iNOS and NADPH Oxidase Expression in a Rat Model of Inflammation
Current Pharmaceutical Biotechnology An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets The Role of Autophagy in Subarachnoid Hemorrhage: An Update
Current Neuropharmacology Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges
Current Drug Targets Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an “Old” Receptor
Current Drug Delivery EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Cyclophilins in Atherosclerosis: A New Therapeutic Target?
Current Pharmaceutical Design COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Current Medicinal Chemistry Potential Genetic Therapies for Acute Lung Injury
Current Gene Therapy Vildagliptin Restores Renal Myogenic Function and Attenuates Renal Sclerosis Independently of Effects on Blood Glucose or Proteinuria in Zucker Diabetic Fatty Rat
Current Vascular Pharmacology A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Oxidative Stress, Preeclampsia and Cardiovascular Disease
Current Hypertension Reviews Proteasome as an Emerging Therapeutic Target in Cancer
Current Pharmaceutical Design Possible Targets of Herbals for Type 3 Diabetes: A Review
Current Traditional Medicine Repeated Transarterial Chemoembolization with Degradable Starch Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study
Current Medical Imaging